Consolidation isn't a bet. It's already happening.

India's pharma distribution looks like every market that consolidated before it. The only open questions are who leads it — and how.

A market without a central system

India's pharmaceutical supply chain connects roughly 3,000 manufacturers to about 9 lakh retail pharmacies through some 80,000 distributors and stockists — the wholesalers that hold stock and resupply pharmacies. There is no central nervous system. Every link runs on personal relationships, paper, and trust built over decades.

For a single pharmacy, that means working with around 20 different distributors just to keep the shelves stocked — each with its own ordering process, its own credit terms, its own delivery rhythm. Multiply that across the country and you get a market that is enormous, essential, and structurally inefficient.

Fragmentation this deep doesn't persist. It resolves. The question is who does the resolving.

We've seen this movie before

The United States ran the same playbook a generation ago. A fragmented field of regional drug wholesalers consolidated until three players — McKesson, Cencora, and Cardinal Health — moved over 90% of the market. Scale won, because distribution is a game of density, working capital, and reach.

India is early on that same curve. The top national players today handle a small share of the market; the overwhelming majority of volume still flows through local distributors. That gap between "today" and "where every comparable market ended up" is the opportunity.

But retail won't consolidate the same way

Here's the nuance most people miss. The last mile stays local. Pharmacies are neighbourhood businesses — trust, proximity, and the person behind the counter matter, and they always will. We don't expect retail to collapse into a few chains.

Distribution is different. It's invisible to the patient and it rewards scale ruthlessly. That's the layer that consolidates — and it's the layer we're building.

Why the window is open now

Timing is not incidental to this thesis; it's central. The would-be national consolidators are, for the moment, looking inward — digesting their own acquisitions, managing listings, or recovering from earlier missteps. M&A competition is muted, and distributors are still priced reasonably relative to the gross merchandise value (GMV) they carry.

That doesn't last. As the large players turn outward again, competition returns and prices rise. The next 24 months are unusually favourable for a disciplined buyer.

Why the operator wins, not the financier

Anyone with capital can buy distributors. Stacking them into a holding company is not a moat — it's a spreadsheet. The difference is what happens after the acquisition.

We run every acquired distributor — and the retailers they serve — on software we own: unified ordering, logistics, and data across the network. That turns a pile of separate businesses into a single operating system, where each new node makes the whole network smarter, cheaper, and harder to displace.

A financial buyer ends up with a bigger company. An operator ends up with infrastructure.

That's the whole thesis: the market is fragmented, the precedent is clear, the window is open, and the winner is the one who owns the rails. We intend to be that operator.

Want the numbers behind the thesis?

The traction, the model, and the deck live in the data room. Serious investors, come on in.